Monti M, De Rosa V, Iommelli F, Carriero MV, Terlizzi C, Camerlingo R, Belli S, Fonti R, Di Minno G, Del Vecchio S

Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2018 Aug 9; 19(8): N/D-N/D.

Iommelli F, De Rosa V, Terlizzi C, Monti M, Panico M, Fonti R, Del Vecchio S

Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by (18)F-fluorothymidine
Clin Cancer Res (ISSN: 1078-0432print, 1078-0432linking), 2018 Jul 1; 24(13): 3126-3136.

Salvatore B, Fonti R, De Renzo A, Pellegrino S, Ferrara IL, Mainolfi CG, Marano L, Selleri C, Pane F, Del Vecchio S, Pace L

2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis
Q J Nucl Med Mol Imaging (ISSN: 1827-1936electronic, 1824-4785linking), 2018 Apr 24; N/D: N/D-N/D.

Ciarmiello A, Fonti R, Giovacchini G, Del Vecchio S

Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives
Clinical And Translational Imaging, 2018; N/D: N/D-N/D.

Modica R, Camera L, NapolitanoV, Avellino M, Fonti R, Del Vecchio S, De LucaL, Colao A, Faggiano A

Tumor Detection in Syndromic NET: Zollinger-Ellison Syndrome
Neuroendocrine Tumors In Real Lif, 2018; e: N/D-N/D.

Segreto S, Fonti R, Ottaviano M, Pellegrino S, Pace L, Damiano V, Palmieri G, Del Vecchio S

Evaluation of metabolic response with (18)F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors
CANCER IMAGING (ISSN: 1470-7330), 2017 Mar 7; 17(1): 10-10.

Monti M, Iommelli F, De Rosa V, Carriero MV, Miceli R, Camerlingo R, Di Minno G, Del Vecchio S

Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells
PLOS ONE (ISSN: 1932-6203), 2017 Feb; 12(2): 1-15.

De Rosa V, Iommelli F, Monti M, Mainolfi CG, Fonti R, Del Vecchio S

Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
Ejnmmi Res, 2016 Dec; 6(1): 74-74.

Iommelli F, De Rosa V, Terlizzi C, Del Vecchio S

Preclinical imaging in oncology: advances and perspectives
Q J NUCL MED MOL IM (ISSN: 1824-4785), 2016 Nov 18; 61(1): 33-47.

Fonti R, Salvatore B, De Renzo A, Nicolai E, Del Vecchio S

Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma
CLIN NUCL MED (ISSN: 0363-9762), 2016 Feb; 41(2): 169-172.

De Luca  S, Fonti R, Camera L, Salvatore B, Faggiano A, Ciarmiello A, Segreto S, Colao A, Salvatore M, Del Vecchio S

Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma
ANN NUCL MED (ISSN: 0914-7187), 2016 Jan 11; 30(3): 1-8.

De Rosa V, Iommelli F, Monti M, Fonti R, Votta G, Stoppelli MP, Del Vecchio S

Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer
CLIN CANCER RES (ISSN: 1078-0432), 2015 Nov 15; 21(22): 5110-5120.

Iommelli F, De Rosa V, Monti M, Panico M, Fonti R, Del Vecchio S

18F-FLT PET/CTas a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC
EUR J NUCL MED MOL I (ISSN: 1619-7070), 2015 Oct; 42: N/D-N/D.

Monti M, De Rosa V, Iommelli F, Fonti R, Pane F, Del Vecchio S

Changes of glycolytic pathway and upregulation of oxidative phosphorylation in BCR-ABL-driven human leukemia cells treated with imatinib
EUR J NUCL MED MOL I (ISSN: 1619-7070), 2015 Oct; 42: N/D-N/D.

De Rosa V, Iommelli F, Monti M, Mainolfi C, Fonti R, Del Vecchio S

Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in NSCLC
EUR J NUCL MED MOL I (ISSN: 1619-7070), 2015 Oct; 42: N/D-N/D.

Fonti R, Pace L, Cerchione C, Catalano L, Salvatore B,  De Luca S, Pane F, Salvatore M, Del Vecchio S

18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study
CLIN NUCL MED (ISSN: 0363-9762), 2015 Apr; 40(4): 303-308.

Fonti R, Pace L, Cerchione C, Catalano L,  De Luca S, Pane F, Salvatore M, Del Vecchio S

18F-FDG-PET/CT, 99mTc-MIBI and MRI in the Prediction of Outcome of Patients with Multiple Myeloma
EUR J NUCL MED MOL I (ISSN: 1619-7070), 2015 Jan 20; 40: 303-308.

Russo P, Larobina M, Di Lillo F, Del Vecchio S, Mettivier G

Combined SPECT/CT and PET/CT for breast imaging
NUCL INSTRUM METH A (ISSN: 0168-9002), 2015; 809: 58-66.

De Rosa V, Iommelli F, Monti M, Fonti R, Del Vecchio S

Early reduction of 18F-FDG uptake in non-small lung cancer treated with EGFR tyrosine kinase inhibitors reflects reversal of Warburg effect and reactivation of oxidative phosphorylation
EUR J NUCL MED MOL I (ISSN: 1619-7070), 2014 Oct; 41: N/D-N/D.

Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Gramanzini M, Fonti R, Del Vecchio S

Monitoring Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by 18F-FLT PET/CT
EUR J NUCL MED MOL I (ISSN: 1619-7070), 2014 Oct; 41: N/D-N/D.

Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Greco A, Gramanzini M, Ortosecco G, Fonti R, Brunetti A, Del Vecchio S

Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Using 3 '-Deoxy-3 '-[F-18]-Fluorothymidine Positron Emission Tomography
CLIN CANCER RES (ISSN: 1078-0432), 2014 Sep 15; 20(18): 4806-4815.

Iommelli F, De Rosa V, Fonti R, Del Vecchio S

Molecular Imaging For Detection Of Sensitivity And Resistance To Egfr Tyrosine Kinase Inhibitors In Non-Small Cell Lung Cancer
Clin Transl Imaging (ISSN: 2281-5872print, 2281-7565online), 2014 Feb 20; 2(1): 43-53.

Ciarmiello A, Gaeta MC, Meniconi M, Milano A, Alfano B, Del Vecchio S, Salvatore M

Parametric MR dynamic imaging for breast lesions characterization and prediction of lymph nodes involvement
Curr Radiopharm (ISSN: 1874-4710, 1874-4729), 2014; 7(2): 91-99.

Russo E, Guerra A, Marotta V, Faggiano A, Colao A, Del Vecchio S, Tonacchera M, Vitale M

Radioiodide induces apoptosis in human thyroid tissue in culture
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Dec; 44(3): 729-734.

 De Luca S, Fonti R, Mainolfi C, Anzivino A, Camera L, Faggiano A, Colao A, Salvatore M, Del Vecchio S

18F-FDG-PET/CT and 111In-Octreotide SPECT in Patients with Metastatic Medullary Thyroid Carcinoma
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.

Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Ortosecco G, Greco A, Gramanzini M, Fonti R, Brunetti A, Del Vecchio S

18F-FLT PET/CT for Detection of Functional Cross-talk between MET and EGFR in Non-small Cell Lung Cancer Resistant to EGFR Inhibitors
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.

De Rosa V, Iommelli F, Votta G, Monti M, Ortosecco G, Fonti R, Mainolfi C, Stoppelli M, Del Vecchio S

Changes of Glycolytic Pathway in Response to Efficient Inhibition of EGFR Signaling in Non-small Cell Lung Cancer (NSCLC)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.

Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R

Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2013 Jan 1; 19(1): 138-147.

De Luca S, Fonti R, Palmieri G, Federico P, Del Prete G, Pacelli R, Pace L, De Placido S, Salvatore M, Del Vecchio S

Combined Imaging With 18f-Fdg-Pet/Ct And 111in-Labeled Octreotide Spect For Evaluation Of Thymic Epithelial Tumors
Clin Nucl Med (ISSN: 1536-0229, 0363-3976, 0363-9762), 2013; 38(5): 354-358.

Fonti R, Larobina M, Del Vecchio S,  de Luca S, Fabbricini R, Catalano L, Pane F, Salvatore M, Pace L

Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Dec; 53(12): 1829-1835.

Zannetti A, Iommelli F, De Rosa V, Nardelli A, Ortosecco G, Del Vecchio S

Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer
European Journal Of Cancer (ISSN: 0959-8049), 2012 Nov; 48: N/D-N/D.

 De Luca S, Palmieri G, Fonti R, Federico P, Del Prete G, Pacelli R, Pace L, Salvatore M, Del Vecchio S

Combined 18F-FDG-PET/CT and 111In-Octreotide SPECT for Evaluation of Thymic Epithelial Tumors
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.

Zannetti A, Iommelli F, De Rosa V, Salvatore M, Del Vecchio S

Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.

Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S

3'-deoxy-3'-18F-fluorothymidine (FLT) PET/CT to guide therapy with epidermal growth factor receptor (EGFR) antagonists and Bcl-xL inhibitors in non-small cell lung cancer
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.

Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S

3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.

Del Vecchio S, Zannetti A, Iommelli F, Fonti R, Speranza A

Stato Dell’arte Dell’imaging Preclinico In Oncologia
Q J Nucl Med Mol Imaging (ISSN: 1827-1936, 1827-1936electronic, 1824-4785linking), 2011; 55: 20-21.

Castaldi E, Ortosecco G, Nardelli A, Speranza A, Del Vecchio S, Zannetti A, Storto G, Pace L, Salvatore M

Automatic radiosynthesis of [F-18]-FBCHO-maleimide linker for Affibody labelling
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Oct; 37: N/D-N/D.

Fonti R, Larobina M,  De Luca S, Fabbricini R, Catalano L, Pace L, Del Vecchio S, Salvatore M

Metabolic Tumor Volume assessed by 18F-FDG-PET/CT in the evaluation of plasma cell mass and prediction of outcome in patients with multiple myeloma
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Oct; 37: N/D-N/D.

Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A

In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jul; 37(7): 1441-1448.

Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Pizzuti LM, Lettieri A, Salvatore M

PET/CT in cancer research: From preclinical to clinical applications
Contrast Media Mol Imaging (ISSN: 1555-4309, 1555-4309linking), 2010 Jul; 5(4): 190-200.

Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M

Molecular imaging of tumor microenvironment
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 243-258.

Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M

Molecular imaging of tumor microenvironment: Challenges and perspectives
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 249-258.

Del Vecchio S, Fonti R, Picchio M, Mapelli P, Gianolli L, Messa C

Capitolo VII: Oncologia
Medicina Nucleare Metodologie Ed Applicazioni Diagnostiche, 2010; N/D: N/D-N/D.

Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A,  De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M

Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.

Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M

Imaging of αvβ3 expression by a bifunctional chimeric RGD peptide not cross-reacting with α vβ5
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.

Ortosecco G, Castaldi E, Nardelli A, Speranza A, Storto G, Del Vecchio S, Pace L, Alfano B, Salvatore M

Automatic two-steps radiosynthesis of [F-18]-Fluoroacetate by commercial synthesizer
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.

Zannetti A, Iommelli F, Fonti R, Lettieri A, Pirozzi G, Bianco R, Tortora G, Salvatore M, Del Vecchio S

Imaging of Bcl-2/Bcl-x(L) dysregulated apoptotic program in NSCLC cells resistant to EGFR tyrosine kinase inhibitors
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.

Zannetti A, Iommelli F, Panico M, Del Gatto A, Zaccaro L, Saviano M, Pedone C, Salvatore M, Del Vecchio S

MicroPET/CT of mice bearing alpha(v)beta(3)-expressing tumors by a 18F-labeled bifunctional chimeric RGD peptide
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.

Panico MM, Lang L, Greco A, Greco A, Gargiulo S, Larobina M, Del Vecchio S, Zannetti A, Zaccaro L, Zaccaro L, Del Gatto A, Saviano M, Alfano B, Salvatore M

New high yield HPLC purification with ethanol of 18F-RGDEchi and directly injection in mice
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.

Fabbricini R, Catalano L, Pace L, Del Vecchio S, Fonti R, Salvatore M, Rotoli B

Bone scintigraphy and SPECT/CT in bisphosphonate-induced osteonecrosis of the jaw
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2009 Aug; 50(8): 1385-1385.

Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Lettieri A, Salvatore M

Molecular imaging of drug resistance in cancer
Minerva Biotecnol (ISSN: 1120-4826), 2009 Mar; 21(1): 31-36.

De Luca S, Del Gatto A, Ruvo M, Panico M, Zannetti A, Del Vecchio S, Salvatore M, Pedone C, Saviano M, Zaccaro L

A new and selective radiolabeled alpha(V)beta(3) peptide antagonist as tracer in tumor diagnosis
Adv Exp Med Biol (ISSN: 0065-2598, 0065-2598print), 2009; 611: 439-440.

Salvatore B, Simeone R, Fonti R, Marciano R, Bianco R, Damiano V, Tortora G, Pace L, Del Vecchio S, Salvatore M

18F-FDG PET/CT in the assessment of early response to chemotherapy and molecularly targeted agents in metastatic colorectal cancer
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.

Panico M, Lang L, Del Vecchio S, Nardelli A, Castaldi E, Zaccaro L, Del Gatto A, Saviano M, Zannetti A, Larobina M, Gargiulo S, Pedone C, Salvatore M

An Improved Radiolabeling Synthesis of RGDECHI with 18F-Fluoride
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.

Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Bianco R, Tortora G, Salvatore M, Del Vecchio S

Imaging of lung cancer resistance to EGFR tyrosine kinase inhibitors through Bcl-2/Bcl-x(L) modulation of inositol trisphosphate receptor type
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.

Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Pirozzi G, Bianco R, Tortora G, Salvatore M, Del Vecchio S

Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2008 Aug 15; 14(16): 5209-5219.

Pulcrano M, Camera L, Pagano L, Del Vecchio S, Ferone D, Bodei L, Murgia A, Pace L, Storto G, Paganelli G, Colao A, Salvatore M, Lombardi G, Biondi B

Usefulness of [(111)In-DTPA(0)] octreotide scintigraphy in a family with von Hippel-Lindau disease
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2008 Apr; 31(4): 352-359.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M

F-18-FDG PET/CT, Tc-99m-MIBI, and MRI in evaluation of patients with multiple myeloma
J Nucl Med (ISSN: 0161-5505, 0161-1550, 1535-5667), 2008 Feb; 49(2): 195-200.

Sirignano C, Fonti R, Soscia E, Iodice D, Del Vecchio S, Salvatore M

Imaging Integrato Del Mieloma Multiplo Con 18fdg-Pet/Tc, Tc99m-Mibi E Rm
La Radiologia Medica, 2008; 113: ISSN-1826.

Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Bianco R, Tortora G, Salvatore M, Del Vecchio S

Imaging Of Lung Cancer Resistance To Egfr Tyrosine Kinase Inhibitors Trough Bcl-2/Bcl-Xl Modulation Of Inositol Trisphosphate Receptor Type
Eur J Nucl Med, 2008; suppl2: N/D-N/D.

Fonti R, Salvatore B, Ricci F, Petruzziello F, Catalano L, Rotoli B, Del Vecchio S, Pace L, Salvatore M

18F-FDG-PET/CT in the evaluation of bone marrow infiltration in patients with multiple myeloma
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: N/D-N/D.

Fonti R, Salvatore B, Ricci F, Petruzziello F, Catalano L, Del Vecchio S, Pace L, Salvatore M, Rotoli B

F-18-FDG-PET/CT in the evaluation of bone marrow infiltration in patients with multiple myeloma
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 2007 Oct; 92: N/D-N/D.

Fonti R, Salvatore B, Ricci F, Petruzziello F, Catalano L, Del Vecchio S, Pace L, Salvatore M, Rotoli B

F-18-FDG-PET/CT, 99mTC-MIBI and MRI in the evaluation of patients with multiple myeloma
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 2007 Oct; 92: N/D-N/D.

Del Vecchio S, Zannetti A, Panico M, Speranza A, Iommelli F, Papaccioli A, Sommella J, Lettieri A, Saviano M, Zaccaro L, Del Gatto A, Lang L, Pedone C, Salvatore M

In vivo imaging of alpha(v) beta(3) integrin expression with a radiolabeled chimeric RGD peptide
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: N/D-N/D.

Zannetti A, Fonti R, Iommelli F, Papaccioli A, Sommella J, Tortora G, Bianco R, Salvatore M, Del Vecchio S

SPECT imaging of endoplasmic reticulum-mediated tumor response to gefitinib and erlotinib in lung cancer
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: 277-309.

Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M

Nuclear imaging in cancer theranostics
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.

Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C, Califano C, Caparrotti G, Segreto S, Pace L, Rotoli B

Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis
Ann Hematol (ISSN: 0939-5555, 0939-5555linking), 2007 Jun; 86(6): 415-423.

Cusanno F, Cisbani E, Colilli S, Fratoni R, Garibaldi F, Giuliani F, Gricia M, Lucentini M, Magliozzi ML, Santarivenere F, Torrioli S, Cinti MN, Pani R, Pellegrini R, Simonetti G, Schillaci O, Del Vecchio S, Salvatore M, Majewski S, De Vincentis G, Scopinaro F

Results of clinical trials with SPEM
Nucl Instrum Methods Phys Res Sect A, 2007 Feb 1; 497(1): 46-50.

Zaccaro L, Del Gatto A,  De Luca S, Ruvo M, Zannetti A, Del Vecchio S, Salvatore M, Pedone C, Saviano M

A new and selective radiolabeled alpha(v)beta 3 peptide antagonist as tracer in tumor diagnosis
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2007; 88(4): N/D-N/D.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Rotoli B, Del Vecchio S, Pace L, Salvatore M

Multimodality Imaging With 18f-Fdg-Pet/Ct, 99mtc-Mibi And Mri Of Multiple Myeloma
Proceedings Of The 2nd International Conference Of The European Society For Molecular Imaging Naples Italy, 2007; N/D: 56-56.

Garibaldi F, Cisbani E, Colilli S, Cusanno F, Fratoni R, Giuliani F, Gricia M, Lucentini M, Fratoni R, Lo Meo S, Magliozzi ML, Santanvenere F, Cinti MN, Pani R, Pellegrini R, Simonetti G, Schillaci O, Del Vecchio S, Salvatore M, Majewski S, Lanza RC, De Vincentis G, Scopinaro F

Molecular imaging: High-resolution detectors for early diagnosis and therapy monitoring of breast cancer
Nucl Instrum Methods Phys Res Sect A (ISSN: 0168-9002), 2006 Dec 20; 569(2SPEC.ISS.): 286-290.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Cammarano F, Segreto S, Petruzziello F, Catalano L, Rotoli B, Del Vecchio S, Pace L, Salvatore M

18F-FDG-PET/CT, 99mTc-MIBI and MRI in the evaluation of patients with multiple myeloma
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.

Del Vecchio S, Zannetti A, Iommelli F, Papaccioli A, Sommella J, Ferraro P, Baiano A, Salvatore M

In vivo detection of early tumor response to tyrosine kinase inhibitors by microSPECT with 99mTc-MIBI
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.

Del Gatto A, Zaccaro L, Grieco P, Novellino E, Zannetti A, Del Vecchio S, Iommelli F, Salvatore M, Pedone C, Saviano M

Novel And Selective Alpha (v) Beta3 Receptor Peptide Antagonist: Design, Synthesis, And Biological Behavior
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2006 Jun 1; 49(11): 3416-3420.

Iommelli F, Zannetti A, Pepe S, Sabbatino F, Laus G, Ghidelli L, Solla R, Scala S, Del Vecchio S, Salvatore M, Pacelli R

Inhibition of NF-kappa B activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 2006 Apr; 47: N/D-N/D.

Pace L, Salvatore M, Del Vecchio S

Use of Tc-99m-Sestamibi scintigraphy in multiple myeloma
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2006 Mar; 47(3): 555-555.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Cammarano F, Segreto S, Petruzziello F, Catalano L, Martinelli V, Rotoli B, Del Vecchio S, Pace L, Salvatore M

18f-Fdg-Pet/Ct, 99mtc-Mibi And Mri Inpatients With Multiple Myeloma
Multimodality Imaging With Proceedings Of The Ix Congress Of The Italian Society Of Experimental Hematology, 2006; PO164: 53-53.

Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Salvatore M

Functional imaging of multidrug resistance in breast cancer
Phys Med (ISSN: 1120-1797, 1120-1797linking), 2006; 21(SUPPL.1): 24-27.

Del Gatto A, Zaccaro L, Zannetti A, Del Vecchio S, Benedetti E, Salvatore M, Pedone C, Saviano M

Novel and selective alpha v beta 3 receptor peptide antagonist: Design, synthesis and biological behaviour
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2006; 12: N/D-N/D.

Zannetti A, Del Vecchio S, Romanelli A, Scala S, Saviano M, Cali' G, Stoppelli MP, Pedone C, Salvatore M

Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells
Biochem Pharmacol Biochemical Pharmacology (ISSN: 0006-2952, 1873-2968), 2005 Nov 1; 70(9): 1277-1287.

Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Sommella I, Potena A, Salvatore M

99mTc-MIBI uptake in Bcl-2 overexpressing breast cancer cells during treatment with gefitinib, a selective tyrosine kinase inhibitor
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: N/D-N/D.

Del Vecchio S, Zannetti A, Del Gatto A, Grieco P, Iommelli F, Zaccaro L, Panico M, Saviano M, Blystone SD, Pedone C, Salvatore M

Characterization of a novel RGD-containing peptide with improved selectivity for imaging alpha v beta 3 integrin expression
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: N/D-N/D.

Catalano L, Andretta C, Pace L, Del Vecchio S, Salvatore B, De Rosa G, Buonanno MT, Paone G, Rotoli B

Tc 99-Sesta Mibi Uptake In Nonsecretory Multiple Myeloma
Hematology (ISSN: 1024-5332), 2005 Sep; 10(4): 335-338.

Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Salvatore B, Andretta C, Di Nuzzo C, Rotoli B, Salvatore M

Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2005 Sep; 49(3): 281-285.

Tauchmanovà L, Pensabene M, Capuano I, Spagnoletti I, Zeppa P, Del Vecchio S, Mainenti PP, De Rosa G, Colao A, Contegiacomo A

Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: Response to chemotherapy and octreotide LAR
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2005 Apr; 28(4): 371-378.

Pace L, Del Vecchio S, Salvatore M

Technetium 99m sestamibi in multiple myeloma
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 2005 Jan; 234(1): 312-313.

Zannetti A, Del Vecchio S, Fonti R, Iommelli F, Sommella J, Potena A, Salvatore M

Gefitinib, A Selective, Tyrosine Kinase Inhibitor Increases 99mtc-Mibi Uptake In Bcl-2 Overexpressing Breast Cancer Cells
Mol Immunol, 2005; 4: 355-355.

Pace L, Del Vecchio S, Salvatore M, Walker RC, Angtuaco E, Sethi R, Fassas A, Barlogie B

Technetium 99m sestamibi in multiple myeloma [3] (multiple letters)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 2005; 234(1): 312-313.

Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Iommelli F, De Renzo A, Rotoli B, Salvatore M

99mTc-MIBI uptake in Bcl-2 overexpressing non-Hodgkin's lymphoma patients during drug-induced apoptosis
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Sep; 31: N/D-N/D.

Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Salvatore M

Tc-99m-MIBI in the evaluation of breast cancer biology
Breast Cancer (ISSN: 9783-540367802), 2004 Jun; 1: 71-81.

Del Vecchio S, Salvatore M

Tc-99m-MIBI in the evaluation of breast cancer biology
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Jun; 31(SUPPL.1): S88-S88.

Aloj L, Caracò C, Panico M, Zannetti A, Del Vecchio S, Tesauro D, De Luca S, Arra C, Pedone C, Morelli G, Salvatore M

In vitro and in vivo evaluation of In-111-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2004 Mar; 45(3): 485-494.

Aloj L, Panico M, Caraco C, Del Vecchio S, Arra C, Affuso A, Accardo A, Mansi R, Tesauro D, De Luca S, Pedone C, Visentin R, Mazzi U, Morelli G, Salvatore M

In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004 Feb; 19(1): 93-98.

Aloj L, Zannetti A, Caracó C, Del Vecchio S, Salvatore M

Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004; 31(4): 521-527.

Catalano L, Andretta C, Pace L, Del Vecchio S, Fonti R, Pollio G, Salvatore B, Esposito C, Salvatore M, Rotoli B

Follow-Up Of Solitary Plasmacytoma By 99mtc-Sestamibi Scintigraphy
Haema (ISSN: 1108-2682), 2004; 7(3): 329-334.

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M

Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.

Pace L, Salvatore M, Del Vecchio S

A new role for nuclear medicine in multiple Myeloma
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2003 Sep; 44(8): 1369-1369.

Del Vecchio S, Zannetti A, Aloj L, Caracò C, Ciarmiello A, Salvatore M

Inhibition of early Tc-99m-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2003 Jun; 30(6): 879-887.

Del Vecchio S, Zannetti A, Aloj L, Salvatore M

MIBI as prognostic factor in breast cancer
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 2003 Mar; 47(1): 46-50.

Camera L, Del Vecchio S, Quarantelli M, Ibello F, Pellegrino T, Salvatore M

Radiolabeled somatostatin analogs in the diagnosis and staging of neuroendocrine tumors
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2003; 26(8Suppl): 60-62.

Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caracò C, Fonti R, Botti G, D'Aiuto G, Salvatore M

Dynamic coupling of Tc-99m-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients
Eur J Nucl Med (ISSN: 1619-7070, 0340-6997, 1619-7089), 2002 Jun; 29(6): 809-814.

Aloj L, Panico M, Caracó C, Zannetti A, Del Vecchio S, Di Nuzzo C, Arra C, Morelli G, Tesauro D, De Luca S, Pedone C, Salvatore M

Radiolabeling approaches for cholecystokinin B receptor imaging
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2002; 66(6): 370-380.

Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Fonti R, Caraco C, Salvatore M

99mTc-MIBI uptake and Bcl-2 overexpression in untreated breast cancer patients
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.

Aloj L, Zannetti A, Caraco C, Fonti R, Del Vecchio S, Salvatore M

99mTc-MIBI uptake in breast cancer cells during early phases of apoptosis induction with Staurosporine
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.

Aloj L, Del Vecchio S, Zannetti A, Caracò C, Salvatore M

99mTc-MIBI uptake is reduced in Bcl-2 overexpressing MCF-7 breast cancer cells
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.

Aloj L, Zannetti A, Caraco C, Del Vecchio S, Tasauro D,  De Luca S, Brunetti A, Aime S, Morelli G, Pedone C

Characterization of 111In labeled CCK8 peptide coupled to a novel DTPA-like derivative in CCK-B receptor overexpressing cells
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.

Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Sica G, Annunziata G, Califano C, Rotoli B, Salvatore M

Wash-out of 99mTc-sestamibi (99mTc-MIBI) in evaluating response to chemotherapy in patients with multiple myeloma (MM)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.

Pace L, Catalano L, Del Vecchio S, Di Gennaro F, De Renzo A, Sica G, Califano C, Tedesco N, Borrelli G, Rotoli B, Salvatore M

Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Mar; 28(3): 304-312.

Imbriaco M, Del Vecchio S, Riccardi A, Pace L, Di Salle F, Di Gennaro F, Salvatore M, Sodano A

Scintimammography with Tc-99m-MIBI versus dynamic MRI for non-invasive characterization of breast masses
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2001 Jan; 28(1): 56-63.

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M

Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001; 28(2): 214-220.

Blocklet D, Schoutens A, Kentos A, Feremans W, Fonti R, Del Vecchio S, Pace L

Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma [1] (multiple letters)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001; 28(9): 1430-1432.

Del Vecchio S, Ciarmiello A, Salvatore M

Scintigraphic detection of multidrug resistance in cancer
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2000 Sep; 15(4): 327-337.

Del Vecchio S, Ciarmiello A, Zannetti A, Fonti R, Botti G, D'Aiuto G, Salvatore M

Efflux rate of Tc-99m-MIBI and apoptosis in untreated breast cancer patients
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2000 May; 41(5): N/D-N/D.

Aloj L, Del Vecchio S, Damiano M, Borrelli G, Di Gennaro F, Imbriaco M, Panico L, Bifano D, Pettinato G, Salvatore M

Washout of Tc-99m-MIBI and prognostic factors in untreated breast cancer patients
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2000 May; 41(5): N/D-N/D.

Zannetti A, Del Vecchio S, Carriero MV, Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M

Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 2000 Mar 15; 60(6): 1546-1551.

Carriero M, Del Vecchio S, Capozzoli M, Franco P, Fontana L, Zannetti A, Botti G, D'Aiuto G, Salvatore M, Stoppelli M

Urokinase receptor interacts with alpha(v)beta(5) vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1999 Oct 15; 59(20): N/D-N/D.

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M

Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.

Aloj L, Del Vecchio S, Damiano M, Zannetti A, Di Gennaro F, Imbriaco M, Salvatore M

Fractional retention of 99mTc-MIBI and proliferation in untreated breast cancer
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.

Del Vecchio S, Fonti R, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M

Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.

Del Vecchio S, Ciarmiello A, Salvatore M

Clinical imaging of multidrug resistance in cancer
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 1999 Jun; 43(2): 125-131.

Di Gennaro F, Catalano L, Pace L, de Renzo A, Pinto AM, del Vecchio S, Rotoli B, Salvatore M

Tc-99m sestamibi scintigraphy in multiple myeloma
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 1999 Feb; 24(2): 115-116.

Esposito G, Tempesta A, Galati MG, De Bellis M, Rossi GB, Potena MI, Marone P, Daniele B, Del Vecchio S

Mucosal expression of carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with gastritis and gastric cancer
Cancer Detect Prev (ISSN: 0361-090x, 0361-090xlinking), 1999; 23(2): 116-122.

Catalano L, Pace L, Califano C, Pinto AM, De Renzo A, Di Gennaro F, Del Vecchio S, Fonti R, Salvatore M, Rotoli B

Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1998 Nov 15; 92(10): 119-124.

Imbriaco M, Sodano A, Riccardi A, Del Vecchio S, Panza M, Limite G, Pace U, Forestieri P, Petrella M, Salvatore G

Accuracy of dynamic contrast-enhanced MR imaging in patients with indeterminate mammograms
European Journal Of Cancer (ISSN: 0959-8049), 1998 Sep; 34: N/D-N/D.

Pace L, Catalano L, Pinto A, De Renzo A, Di Gennaro F, Califano C, Del Vecchio S, Rotoli B, Salvatore M

Different patterns of technetium-99m sestamibi uptake in multiple myeloma
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1998 Jul; 25(7): 714-720.

Salvatore M, Del Vecchio S

Dynamic imaging: Scintimammography
Eur J Radiol Elsevier Sci Ireland Ltd (ISSN: 0720-048x), 1998 May; 27(SUPPL.2): S259-S259.

Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, Botti G, D'Aiuto G, Salvatore M

Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer
Journal Of Clinical Oncology (ISSN: 0732-183x), 1998 May; 16(5): 1677-1683.

Pasquali D, Bellastella A, Valente A, Botti G, Capasso I, del Vecchio S, Salvatore M, Colantuoni V, Sinisi AA

Retinoic acid receptors α, β and γ, and cellular retinol binding protein-I expression in breast fibrocystic disease and cancer
Eur J Endocrinol (ISSN: 0804-4643), 1997 Oct; 137(4): 410-414.

Del Vecchio S, Ciarmiello A, Pace L, Potena MI, Carriero MV, Mainolfi C, Thomas R, D'Aiuto G, Tsuruo T, Salvatore M

Fractional retention of technetium-99m-sestamibi as an index of P- glycoprotein expression in untreated breast cancer patients
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 Sep; 38(9): 1348-1351.

Carriero MV, Del Vecchio S, Franco P, Potena MI, Chiaradonna F, Botti G, Stoppelli MP, Salvatore M

Vitronectin binding to urokinase receptor in human breast cancer
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 1997 Sep; 3(8): 1299-1308.

Ciarmiello A, Del Vecchio S, Carriero MV, Silvestro P, Botti G, Potena MI, D'Aiuto G, Salvatore M

Efflux rate of Tc-99m-Sestamibi as a predictor of the outcome of therapy in patients with advanced breast carcinoma
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 May; 38(5SUPPL.): N/D-N/D.

Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M

Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.

Ciarmiello A, Del Vecchio S, Potena MI, Carriero MV, Silvestro P, Botti G, D'Aiuto G, Tsuruo T, Salvatore M

99mTc-Sestamibi efflux and therapeutic response in patients with advanced breast carcinoma
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 1996; 37(0): N/D-N/D.

Del Vecchio S, Ciarmiello A, Potena MI, Carriero MV, Thomas R, D'Aiuto G, Tsuruo T, Salvatore M

Detection of multidrug-resistant phenotype by 99mTc-Sestamibi scan in patients with breast carcinoma
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 1996; 37(0): N/D-N/D.

Del Vecchio S, Ciarmiello A, Potena MI, Carriero MV, Mainolfi C, Botti G, Tsuruo T, Salvatore M

Quantitation of P-glycoprotein in sections of human breast carcinoma
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1995; 36(5SUPPL.): N/D-N/D.

Ciarmiello A, Del Vecchio S, Potena MI, Mainolfi C, Carriero MV, Tsuruo T, Marone A, Salvatore M

Tc-99m-SESTAMIBI efflux and P-glycoprotein expression in human breast carcinoma
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1995; 36(5SUPPL.): N/D-N/D.

Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M

Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1994 Oct 15; 54(20): 5445-5454.

Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M

IN-VITRO RECEPTOR IMAGING FOR CHARACTERIZATION OF HUMAN SOLID TUMORS
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1994 Jul; 21(5): 771-774.

Carriero MV, Stoppelli MP, Del Vecchio S, Franco P, Massa O, Fonti R, Salvatore M

Comparative distribution of urokinase receptor and urokinase in human breast cancer
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 1994; 35(0): N/D-N/D.

Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR

CYTOSINE-ARABINOSIDE INCREASES THE BINDING OF I-125 LABELED EPIDERMAL GROWTH-FACTOR AND I-125 TRANSFERRIN AND ENHANCES THE IN-VITRO TARGETING OF HUMAN TUMOR-CELLS WITH ANTI-(GROWTH FACTOR-RECEPTOR) MAB
Cancer Immunol Immunother (ISSN: 0340-7004, 0340-7004linking), 1993 Sep; 37(3): 150-156.

Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR

Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb
Cancer Immunol Immunother (ISSN: 0340-7004linking), 1993 Aug; 37 (3 ): 150-156.

Del Vecchio S, Stoppelli MP, Carriere MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M

Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1993 Jul 1; 53(13): 3198-3206.

Caraglia M, Correale P, Genua G, Pepe S, Del Vecchio S, Esposito G, Bianco AR, Tagliaferri P

EPIDERMAL GROWTH-FACTOR (EGFR) AND TRANSFERRIN (TRFR) RECEPTOR UP-REGULATION IS INDUCED BY ARABINOSIDE CYTOSINE (ARA-C) ON HUMAN TUMOR-CELLS
Cancer Detection And Prevention (ISSN: 0361-090x), 1993; 17(2): 337-338.

Maglione D, Guerriero V, Viglietto G, Ferraro MG, Aprelikova O, Alitalo K, Del Vecchio S, Lei KJ, Chou JY, Persico MG

Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14
Oncogene (ISSN: 0950-9232, 1476-5594), 1993; 8(4): 925-931.

Del Vecchio S, Stoppelli P, Fonti R, Carriero MV, Li P, Salvatore M

Urokinase and urokinase receptor overexpression in breast carcinoma as compared to benign lesions
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 1993; 34(0): N/D-N/D.

Sofia M, Del Vecchio S, Petrillo A, Mormile M, Salvatore M, Carratù L

Endobronchial deposition of radioactive monoclonal antibody in patients with inoperable non-small-cell carcinoma of the lung [4]
Chest (ISSN: 0012-3692), 1992 Nov; 102(5): 1632-1634.

Lakshmanan M, Reynolds JC, Del Vecchio S, Merino MJ, Norton JA, Robbins J

PELVIC RADIOIODINE UPTAKE IN A RECTAL WALL TERATOMA AFTER THYROIDECTOMY FOR PAPILLARY CARCINOMA
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1992 Oct; 33(10): 1848-1850.

D'Aiuto G, Del Vecchio S, Mansi L, D'Aprile M, Botti G, Salvatore M

Malignant melanoma of the nipple: A case studied with radiolabeled monoclonal antibody
Tumori (ISSN: 0300-8916, 0300-8916print), 1991 Oct 31; 77(5): 449-451.

Camera L, Del Vecchio S, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M

Evaluation of therapeutic response using iodine-131-B72. 3 monoclonal antibody in patients with ovarian carcinoma
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991 Apr; 18(4): 269-273.

Del Vecchio S, Camera L, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M

Clinical studies with B72. 3 in ovarian cancer and probe-guided tumor localization
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1991; 18(1): 85-87.

Del Vecchio S, Mansi L, Petrillo A, Camera L, Sofia M, Marra A, Carratú L, Salvatore M

Endobronchial administration of iodine-131 B72. 3 monoclonal antibody in patients with lung cancer
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991; 18(2): 129-132.

Del Vecchio S, Reynolds JC

NONUNIFORM DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY IN TUMOR
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1990 Jul; 31(7): 1252-1252.

Steis RG, Carrasquillo JA, Mccabe R, Bookman MA, Reynolds JC, Larson SM, Smith JW, Clark JW, Dailey V, Del Vecchio S

Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma
J Clin Oncol (ISSN: 0732-183x, 0732-183xlinking), 1990 Mar; 8(3): 476-490.

Reynolds JC, Del Vecchio S, Sakahara H, Lora ME, Carrasquillo JA, Neumann RD, Larson SM

ANTI-MURINE ANTIBODY RESPONSE TO MOUSE MONOCLONAL ANTIBODIES CLINICAL FINDINGS AND IMPLICATIONS
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 121-125.

Salvatore M, Lastoria S, Del Vecchio S, Mansi L

Detection of colon cancer with radiolabelled monoclonal antibodies
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1989; 16(2): 103-104.

Del Vecchio S, Reynolds JC

DETERMINATION OF ANTIGEN CONCENTRATION AND DISTRIBUTION IN HUMAN TUMORS THE QUANTITATIVE AUTORADIOGRAPHIC APPROACH
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 143-145.

Del Vecchio S, Reynolds JC, Carrasquillo JA, Blasberg RG, Neumann RD, Lotze MT, Bryant GJ, Farkas RJ, Larson SM

Local distribution and concentration of intravenously injected 131I-9. 2. 27 monoclonal antibody in human malignant melanoma
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1989; 49(10): 2783-2789.

DEL VECCHIO S, MANSI L, GAGLIARDI N, PETRILLO A, SOFIA M, CARRATU L, SALVATORE M

INTRABRONCHIAL ADMINISTRATION OF IODINE-131 B72. 3 MONOCLONAL ANTIBODY IN PATIENTS WITH LUNG CANCER
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1988; 14(5-6): N/D-N/D.

Del Vecchio S, Reynolds JC, Blasberg RG, Neumann RD, Carrasquillo JA, Hellström I, Larson SM

Measurement of local Mr 97, 000 and 250, 000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1988; 48(19): 5475-5481.